Offstream
news

---

Changes

1. A late-stage trial of oral drug named Paxlovid conducted by Pfizer shown a 89% cut of hospitalization and death risk, making them halts their trial due to "overhelmed efficiacy.
   2021-11-06 01:06:23 (First version)
2. A late-stage trial of the oral drug Paxlovid conducted by Pfizer shows an 89% reduction in hospitalizations and deaths.
   (Current version)

---

Related

Rady Children's Hospital in San Diego administers the first vaccines to children between the ages of 5 and 11 years old after Pfizer's COVID-19 vaccine was approved for use in children by the U.S. CDC.
2021-11-3

Switzerland signs an agreement with Pfizer to supply a total of 14 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 and 2023, which also includes an option to supply an additional 7 million vaccine doses in subsequent years.
2021-08-25

Bennett also announces that he has spoken with Pfizer CEO Albert Bourla about swapping doses of the Pfizer COVID-19 vaccine to other countries.
2021-07-4

The government announces a deal with Pfizer to receive 14 million doses of its COVID-19 vaccine by June, and a total of 99 million doses by the end of the year.
2021-03-8

Pfizer says that they will supply 40 million doses of their vaccine to lower- and middle-income countries.
2021-01-22

Supreme Leader Ali Khamenei calls for a ban on the American Pfizer and British AstraZeneca vaccines.
2021-01-8

Prime Minister Lee Hsien Loong says that Singapore has approved the Pfizer-BioNTech vaccine. The country expects to receive shipments of the vaccine by the end of the year and to vaccinate 5.7 million people for free by the third quarter of 2021.
2020-12-14

The Health Ministry announces that Spain will receive 20 million vaccine doses from Pfizer and BioNTech by early 2021.
2020-11-10

Pfizer announces that it has received approval from the Food and Drug Administration for vaccine trials on children at least 12 years old. The trials are expected to begin at the Cincinnati Children's Hospital Medical Center in Ohio.
2020-10-13

American company Pfizer and German company BioNTech say that they are on track to being submitted for regulatory review as early as October.
2020-08-21